Kees Nooter

11.0k citations
158 papers · 9.5k · 2 hit papers · h-index 52

Impact in

  • Oncology top 0.2%
    • Drug Transport and Resistance Mechanisms
    • Cancer Treatment and Pharmacology
  • Hematology top 1%

Papers in

    • Drug Transport and Resistance Mechanisms 48
    • Cancer Treatment and Pharmacology 17
    • Neutropenia and Cancer Infections 13
    • Cancer therapeutics and mechanisms 39
    • RNA Interference and Gene Delivery 10

Kees Nooter

155 papers receiving 9.1k citations

Kees Nooter's Hit Papers

Cremophor EL 2001 · 1.4k citations
1.4k0+8+16Years since publication4008001.2k

Peers

Kees Nooter
Comparison fields: 5 of 135
  • Oncology 5.0k
  • Hematology 845
  • Biomaterials 988
  • Pharmacology 491
  • Pharmaceutical Science 356
Replace Merrill J. Egorin with:
Merrill J. Egorin United States
G. Stoter Netherlands
T Tsuruo Japan
Ross C. Donehower United States
Yehuda G. Assaraf Israel
Gergely Szakács Hungary
Douglas D. Ross United States
Robert W. Robey United States
Antonio Tito Fojo United States
Maurizio D’Incalci Italy
Kees Nooter relative to Merrill J. Egorin United States Merrill J. Egorin's profile →
Citations per field
00.5×2.9×
Merrill J. Egorin · 1×
Citations per year

Countries citing papers authored by Kees Nooter

Since Specialization
Citations

This map shows the geographic impact of Kees Nooter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kees Nooter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kees Nooter more than expected).

Fields of papers citing papers by Kees Nooter

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kees Nooter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kees Nooter. The network helps show where Kees Nooter may publish in the future.

Co-authors

The 25 scholars most cited alongside Kees Nooter, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Kees Nooter Line = papers co-authored together Kees Nooter links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 158 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Cremophor EL
Hit paper breakdown →
20011439
2
Clinical pharmacokinetics and metabolism of irinotecan (CPT-11).
Hit paper breakdown →
2001656
3 2004344
4
Cremophor EL-mediated alteration of paclitaxel distribution in human blood: clinical pharmacokinetic implications.
1999298
5 1992282
6
RNA expression of breast cancer resistance protein, lung resistance-related protein, multidrug resistance-associated proteins 1 and 2, and multidrug resistance gene 1 in breast cancer: correlation with chemotherapeutic response.
2003258
7 1990194
8 1991186
9 2005168
10 1996152
11
Expression of the multidrug resistance-associated protein (MRP) gene in human cancers.
1995152
12 1996145
13 1993136
14 2005133
15 2005131
16 1997131
17 2001118
18 1990117
19 2005109
20 1992108

About Kees Nooter

Kees Nooter is a scholar working on Oncology, Molecular Biology, Hematology, Genetics and Surgery, having authored 158 papers that have together received 9.5k indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (48 papers), Cancer therapeutics and mechanisms (39 papers), Cancer Treatment and Pharmacology (17 papers), Virus-based gene therapy research (16 papers), Neutropenia and Cancer Infections (13 papers), RNA Interference and Gene Delivery (10 papers), Acute Myeloid Leukemia Research (10 papers) and Acute Lymphoblastic Leukemia research (9 papers). The work is most often cited by research in Oncology (5.0k citations), Hematology (845 citations), Biomaterials (988 citations), Pharmacology (491 citations) and Pharmaceutical Science (356 citations). Kees Nooter has collaborated with scholars based in Netherlands, United States and Germany. Frequent co-authors include Alex Sparreboom, Jaap Verweij, G. Stoter, Hans Gelderblom, Pieter Sonneveld, Hans Herweijer, Walter J. Loos, Herman Burger, Antonius W.M. Boersma and Peter de Bruijn. Their work appears in journals such as International Journal of Cancer, British Journal of Cancer, Cancer Chemotherapy and Pharmacology, Journal of Clinical Oncology and European Journal of Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact